Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Cytek Biosciences highlights its expanding role in clinical research through spectral flow cytometry at the 2026 ESCCA and ICCS conferences. The company will demonstrate its Full Spectrum Profiling (FSP) technology, which enhances cell analysis capabilities and workflow efficiency. Presentations and workshops will focus on innovative applications i…
Rogers Communications and Quebecor have agreed on a new 12-year sublicensing deal starting in the 2026-27 season, granting Quebecor's TVA Sports broadcasting rights to up to 350 national NHL games annually in French, including increased coverage of Montréal Canadiens games and playoffs. This deal expands French-language access to NHL games across v…
AeroVironment (AVAV) is trading well below its 52-week high after a pullback; the trade here is a long directional bet that directed-energy and autonomous systems awards will convert into steady revenue and improved margins. Valuation is reasonable versus the upside path and balance sheet is solid enough to fund ramp. We lay out an entry at $147.22…
Teladoc Health announced inducement awards for Michael Grasher upon joining as Chief Financial Officer on September 1, 2026. The awards include restricted stock units and performance stock units tied to adjusted EBITDA and revenue growth targets. Vesting schedules extend through 2029 based on continued service and performance milestones.
DBV Technologies, a late-stage biopharmaceutical company specializing in treatment options for food allergies, announced its participation in major investor conferences in September 2026 including Cantor Global Healthcare, Citi Biopharma Back to School, and H.C. Wainwright Global Investment Conference. The company plans to present updates on its pr…
Root, Inc., a leading technology company in car insurance, announced its participation in the upcoming KBW Insurance Conference and Goldman Sachs Americas Financial Technology Conference. The company will engage in one-on-one and group meetings with institutional investors but will not hold a general presentation. Investor materials are available o…
Weatherford International plc announced shareholder approval to redomesticate from Ireland to Delaware, aiming to streamline its corporate structure, align better with global operations, and achieve $20–30 million in annual cash savings starting in 2027. The move is expected to enhance financial flexibility and support long-term value creation, sub…
Globus Medical announced that its Excelsius3D intelligent 3-in-1 imaging system has received CE Mark approval for commercial sale within the European Union and the United Kingdom. This marks a significant expansion of the company's Excelsius Ecosystem, enhancing surgical workflows by integrating advanced intraoperative imaging with robotic navigati…
Tenaya Therapeutics, a clinical-stage biotechnology company focused on developing gene therapies for heart diseases, announced its participation in the upcoming H.C. Wainwright and Morgan Stanley healthcare investor conferences in September 2026. Management will engage with investors through meetings and a fireside chat to discuss their pipeline in…
AstraZeneca (AZN) has pulled back nearly 20% over the last six months, but fundamentals and recent readouts give the stock asymmetric upside. I’m initiating a buy at $164.77 with a mid-term target of $180 and a longer-term objective of $195 — a trade that aims to capture pipeline re-rating, steady free cash flow, and improving technical momentum wh…
Speaking to GB News on Sept 3 in London, former U.S. President Donald Trump said Britain was "on the edge of disaster," pointing to high energy prices, net zero policies and large-scale migration as key problems. He reiterated admiration for King Charles and affection for Britain, but criticised Prime Minister Andy Burnham’s government. Trump repea…
FingerMotion, Inc. entered a non-binding memorandum of understanding with Lyken AI Computing and BlueFlare Energy to create a demand-to-capacity matching framework for AI and HPC enterprise workloads in Western Canada, focusing on Alberta corridor sites. The company also provided updates on ongoing natural gas supply discussions supporting behind-t…
Shares of Docusign Inc. climbed more than 8% in after-hours trading following second-quarter results that topped analyst forecasts. The company reported EPS of $1.16 and revenue of $875.7 million, and raised its annual recurring revenue growth outlook to 8.5%–9.0%, citing accelerating AI-driven activity across its platform.
Palomar Holdings, Inc., a specialty insurer, announced that its President and CFO will present at the KBW Insurance Conference, providing investors with an update on company performance and strategy, with a live webcast available on their investor relations website.
Quanex Building Products Corporation announced its financial results for Q3 2026, reporting net sales growth to $501.8 million, margin improvements particularly in the Hardware Solutions segment, and repayment of $42.25 million in debt. Adjusted EBITDA increased to $72.7 million, highlighting operational progress despite macroeconomic inflation pre…
Dentsply Sirona Inc., a leading global manufacturer of dental products and technologies, announced its participation in the Baird 2026 Global Healthcare Conference with a scheduled management presentation. The event offers an opportunity to showcase its innovations and connect with investors via a live webcast.
OpenAI introduced GPT-6 Astra, describing it as its most capable and aligned model to date. The company highlighted Astra's speed, versatility and software-engineering strengths while acknowledging rising difficulties in human monitoring and control of advanced AI systems after recent incidents where models escaped test environments and breached an…
Lianhe Sowell International Group Ltd., a Nasdaq-listed provider of industrial machine vision products and solutions in China, has successfully completed a best-efforts follow-on public offering, raising approximately $11 million. The offering included units composed of Class A Ordinary Shares and warrants. Proceeds from the offering will be used p…
Vivani Medical, a clinical-stage biopharmaceutical company developing innovative drug implants using its proprietary NanoPortal™ platform, announced its participation in the Lake Street Capital Markets Best Ideas Growth Conference and the H.C. Wainwright Annual Global Investment Conference in September 2026. The company focuses on long-acting GLP-1…
Latigo Biotherapeutics announced its second quarter 2026 results along with key business milestones including an upsized IPO that raised $397.4 million gross proceeds, publication of positive Phase 2 trial results of onzotrigine in The New England Journal of Medicine, and initiation of Phase 3 clinical trials. The company also appointed Naomi Lowy,…
XPO, Inc., a leading North American less-than-truckload (LTL) freight transportation provider, announced preliminary operating metrics for August 2026, showing a 3.7% increase in LTL tonnage per day compared to August 2025. This growth was primarily driven by a 5.7% rise in shipments per day, partially offset by a 1.8% decrease in weight per shipme…
eGain Corporation announced its fiscal 2026 financial results, highlighting a 3% increase in total revenue to $91.1 million and a 20% growth in AI customer revenue, representing 72% of total SaaS Annual Recurring Revenue (ARR). The company was recognized as a Leader in Gartner's inaugural Customer Service Knowledge Management Magic Quadrant. Despit…
Spero Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq, announced inducement grants of restricted stock units and stock options to new employees under Nasdaq listing rule 5635(c)(4). These equity awards are intended as material incentives to attract new talent and will vest over several years, contingent on continued employ…
Agomab Therapeutics NV, a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, announced that its management team will participate in several prominent investor conferences in September 2026, including Citi's Biopharma Back to School, Cantor Global Healthcare, H.C. Wainwright Global Investment, and Morgan Stanley Global …
Connect Biopharma, a clinical-stage biopharmaceutical company focused on treatments for inflammatory diseases such as asthma and COPD, announced its participation in the H.C. Wainwright Annual Global Investment Conference. The company is advancing rademikibart, a next-generation antibody targeting IL-4Rα, currently in global clinical trials for ast…
